What Researchers Did
Researchers in China studied 248 patients with cirrhosis and poor wound healing to evaluate how a multidimensional combination of treatments, including hyperbaric oxygen therapy, affected their wound healing.
What They Found
After 3 months, wound sizes significantly decreased across all cirrhosis severity levels, for example, from 2.4 to 1.7 cm2 in mild cases and 6.2 to 4.4 cm2 in severe cases. Over 6 months, healing rates improved to 90% for mild, 75% for moderate, and 45% for severe cirrhosis patients. Albumin levels also increased by an average of 0.3-0.4 g/dL, though infection rates ranged from 10% in mild to 30% in severe cases.
What This Means for Canadian Patients
For Canadian patients with cirrhosis experiencing poor wound healing, this study suggests that a comprehensive approach including hyperbaric oxygen therapy could be beneficial. While hyperbaric oxygen therapy is not a standard treatment for cirrhosis-related wounds in Canada, these findings highlight its potential as part of a multi-faceted care plan to improve healing and nutritional status.
Canadian Relevance
No direct Canadian connection identified. The study was conducted in Shanghai, China, and while it involved hyperbaric oxygen therapy, wound healing in cirrhosis is not a Health Canada-recognized indication for HBOT.
Study Limitations
As an observational cohort study using a combination of therapies, it is difficult to determine the specific impact of hyperbaric oxygen therapy alone on the observed wound healing improvements.